Axis pays Skr75 million for alcoholism test:
This article was originally published in Clinica
Executive Summary
Axis has bought the rights to Pharmacia and Upjohn's product line for the diagnosis of long-term high alcohol consumption for Skr75 million ($9.4 million). As a result, the Norwegian company claims it will be the world leader in the alcohol-related diagnosis market. The agreement gives Oslo-based Axis the products, patent rights and applications, brands and research projects, with effect from October 1 1998.